Clinical Trials Logo

Exercise-induced Bronchospasm clinical trials

View clinical trials related to Exercise-induced Bronchospasm.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04234464 Completed - Clinical trials for Exercise Induced Bronchospasm

A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma

TYREE
Start date: January 15, 2020
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, single-dose, placebo-controlled, 2-period, crossover study to evaluate the efficacy and safety of budesonide/albuterol metered-dose inhaler (BDA MDI/PT027) as compared with a placebo metered-dose inhaler (placebo MDI) on exercise-induced bronchoconstriction (EIB) in adult and adolescent subjects with asthma. Subjects will receive each study treatment on separate visits and undergo a treadmill exercise challenge test for up to 10 minutes so that the effect of study treatment on exercise-induced bronchoconstriction can be evaluated.

NCT ID: NCT00701025 Completed - Clinical trials for Exercise-induced Bronchospasm

Mechanisms of Exercise-induced Bronchospasm

Start date: April 2008
Phase:
Study type: Observational

The term exercise-induced bronchospasm (EIB) describes acute, transient airway narrowing that occurs during, and most often after, exercise. Manifestations of EIB can range from mild impairment of performance to severe bronchospasm and respiratory failure. The pathogenesis of EIB remains controversial and the role of airway inflammation has not yet been definitively characterized. We plan on comparing markers of inflammation in asthmatic participants with and without EIB at baseline and after bronchoprovocation with eucapnic voluntary hyperventilation testing (EVH). We also will collect demographic information as well as information about asthma control and exercise habits.

NCT ID: NCT00273689 Completed - Clinical trials for Exercise Induced Bronchospasm

Exercise Induced Bronchospasm in Children

Start date: December 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.

NCT ID: NCT00268723 Completed - Clinical trials for Exercise-induced Bronchospasm

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Start date: December 2005
Phase: Phase 3
Study type: Interventional

To determine if administration of levalbuterol tartrate HFA MDI in subjects with EIB will be effective in the prevention of EIB and be safe and well-tolerated.

NCT ID: NCT00085774 Completed - Clinical trials for Exercise-induced Bronchospasm

Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

Start date: June 30, 2004
Phase: Phase 3
Study type: Interventional

This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.